Abstract
Protein kinase C (PKC) eta is a PKC isoform whose upregulation is associated with differentiation in many epithelial tissues, including the rat mammary gland. The purpose of this study was to examine whether PKC eta is altered, in expression or localization, in human breast cancer. Paraffin sections of 49 in situ breast lesions, 29 invasive breast tumors, and nine normal breast biopsies were examined for PKC eta expression by immunohisto chemistry. Adjacent regions of normal epithelium, and in situ lesions that were present adjacent to invasive lesions were also analyzed. In normal epithelium, regardlessof the presence of adjacent in situ or invasive lesions, PKC eta was present in the cytoplasm of the luminal epithelium, and increased inareas of normal lobular development, similar to normal rat mammary gland. PKC eta staining intensity was homogeneous in normal lobules, but heterogeneous in in situ and invasive lesions, being focally increased in cells with aberrant nuclear morphology. In situ lesions were similar to adjacent normal epithelium in average staining intensity, regardless of whether invasion was also present. However, the invasive lesions themselves were significantly decreased in staining intensity compared to adjacent in situ lesions. In addition, 75% of invasive breast cancer lesions showed decreased staining relative to adjacent normal epithelium, compared to 37% of in situ lesions. The invasive tumors which possessed high PKC eta staining were associated with positive lymph node status. These results demonstrate that quantitative and qualitative alterations in PKC eta occur in human breast cancers.
Similar content being viewed by others
References
Deacon EM, Pongracz J, Griffiths G, Lord JM: Isoenzymes of protein kinase C: differential involvement in apoptosis and pathogenesis. J Clin Pathol Clin Mol Pathol 50: 124-131, 1997
Mellor H, Parker PJ: The extended protein kinase C superfamily. Biochem J 332: 281-292, 1998
Caulfield JJ, Bolander FF, Jr: Involvement of protein kinase C in mouse mammary gland development. J Endocrinol 109: 29-34, 1986
Connor K Clegg RA: Isoenzymes of protein kinase C in rat mammary tissue: changes in properties and relative amounts during pregnancy and lactation. Biochem J 291: 817-824, 1993
Foncea R, Varela S, Sapag-Hagar M, Lavandero S: Changes in protein kinase C activity, subcellular distribution and protein phosphorylation during the lactogenic cycle in rat mammary tissue. Res Comm Mol Pathol Pharmacol 87: 253-268, 1995
Holladay CS, Bolander FFJ: Hormonal regulation of protein kinase C in the mouse mammary gland. Proc Soc Exp Biol Med 183: 343-347, 1986
Gordge PC, Hulme MJ, Clegg RA, Miller WR: Elevation of protein kinase A and protein kinase C activities in malignant as compared with normal human breast tissue. Eur J Cancer 32A: 2120-2126, 1996
Davidson NE, Kennedy MJ: Protein kinase C and breast cancer. In: Dickson R, Lippman M (eds) Mammary Tumor Cell Cycle, Differentiation and Metastasis. Kluwer Academic Publishers, NY, 1996, pp 91-105
O'Brian CA, Vogel VG, Singletary SE, Ward NE: Elevated protein kinase C expression in human breast tumor biopsies relative to normal breast tissue. Cancer Res 49: 3215-3217, 1989
Kiley SC, Welsh J, Narvaez C, Jaken S: Protein kinase C isozymes and substrates in mammary carcinogenesis. JMamm Gland Biol Neoplasia 1: 177-187, 1996
Taketani Y, Oka T: Tumor promoter 12-O-tetradecanoylphorbol 13-acetate, like epidermal growth factor, stimulates cell proliferation and inhibits differentiation of mouse mammary epithelial cells in culture. Proc Natl Acad Sci, USA 80: 1646-1649, 1983
Rillema JA, Sluyser M: Increased sensitivity of mouse mammary gland for hormones and tumor promoter 12-O-tetradecanoyl-phorbol-13-acetate in tissues containing the MMTV-2 gene. Horm Res 19: 52-56, 1984
Starzec A, Spanakis E, Nehme A, Salle V, Veber N, Mainguene C, Planchon P, Valette A, Prevost G, Israel L: Proliferative effects of epithelial cells to 8-bromo-cyclic AMP and to a phorbol ester change during breast pathogenesis. J Cell Physiol 161: 31-38, 1994
Wada T, Darcy KM, Guan X, Ip MM: Phorbol 12-myristate 13-acetate stimulates proliferation and ductal morphogenesis and inhibits functional differentiation of normal rat mammary epithelial cells in primary culture. J Cell Physiol 158: 97-109, 1994
Birkenfeld HP, McIntyre BS, Briski KP, Sylvester PW: Protein kinase C isoenzyme expression in normal mouse mammary epithelial cells grown in primary culture. Proc Soc Exp Biol Med 213: 65-70, 1996
Darbon J-M, Valette A, Bayard F: Phorbol esters inhibit the proliferation of MCF-7 cells. Biochem Pharm 35: 2683-2686, 1986
Kennedy MJ, Prestigiacomo LJ, Tyler G, May WS, Davidson NE: Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines. Cancer Res 52: 1278-1283, 1992
Issandou M, Bayard F, Darbon J-M: Inhibition of MCF-7 cell growth by 12-O-tetradecanoylphorbol-13-actetate and 1,2-dioctanoyl-sn-glycerol: distinct effects on protein kinase C activity. Cancer Res 48: 6943-6950, 1988
Fabbro D, Regazzi R, Costa SD, Borner C, Eppenberger U: Protein kinase C desensitization by phorbol esters and its impact on growth of human breast cancer cells. Biochem Biophy Res Commun 135: 65-72, 1986
Osborne CK, Hamilton B, Nover M, Ziegler J: Antagonism between epidermal growth factor and phorbol ester tumor promoters in human breast cancer cells. J Clin Invest 67: 943-951, 1981
Valette A, Gas N, Jozan S, Roubinet MA, Dupont MA, Bayard F: Influence of 12-O-tetradecanoylphorbol-13-acetate on proliferation and maturation of human breast carcinoma cells (MCF-7): relationship to cell cycle events. Cancer Res 47: 1615-1620, 1987
Mehta RG Moon RC: Effects of 12-O-tetradecanoylphorbyl 13-acetate on carcinogen-induced mouse mammary lesions in organ culture. Cancer Res 46: 5832-5835, 1987
O'Brian CA, Housey GM, Weinstein IB: Specific and direct binding of protein kinase C to an immobilized tamoxifen analogue. Cancer Res 48: 3626-3629, 1988
Edashige K, Sato EF, Akimaru K, Yoshioka T, Utsumi K: Nonsteroidal antiestrogen suppresses protein kinase C-its inhibitory effect on interaction of substrate protein with membrane. Cell Struct Funct 16: 273-281, 1991
Bignon E, Ogita K, Kishimoto A, Nishizuka Y: Protein kinase C subspecies in estrogen receptor-positive and-negative human breast cancer cell lines. Biochem Biophy Res Commun 171: 1071-1078, 1990
Kiss Z, Anderson WH: Inhibition of phorbol ester-stimulated phospholipase D activity by chronic tamoxifen treatment in breast cancer cells. FEBS Lett 400: 145-148, 1997
Clarke R: Animal models of breast cancer: their diversity and role in biomedical research. Breast Cancer Res Treat 39: 1-6, 1996
O'Brian CA, Liskamp RM, Solomon DH, Weinstein IB: Inhibition of protein kinase C by tamoxifen. Cancer Res 45: 2462-2465, 1985
Kiley SC, Jaken S, Whelan R, Parker PJ: Intracellular targeting of protein kinase C isoenzymes: functional implications. Biochem Soc Transac 23: 601-605, 1995
Nishizuka Y: The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 308: 693-698, 1984
Nishizuka Y: Studies and prospectives of the protein kinase C family for cellular regulation. Cancer 63: 1892-1903, 1989
Lavie Y, Zhang Z-C, Cao H-T, Han T-Y, Jones RC, Liu Y-Y, Jarman M, Hardcastle IR, Giuliano AE, Cabot MC: Tamoxifen induced selective membrane association of protein kianse C epsilon in MCF-7 human breast cancer cells. Int J Cancer 77: 928-932, 1998
Masso-Welch PA, Verstovsek G, IpMM: Alterations in the expression and localization of protein kinase C isoforms during mammary gland differentiation. Eur J Cell Biol 78: 497-510, 1999
Masso-Welch PA, Verstovsek G, Darcy K, Tagliarino C, Ip MM: Protein kinase C eta upregulation and secretion during postnatal rat mammary gland differentiation. Eur J Cell Biol 77: 48-59, 1998
Ohba M, Ishino K, Kashiwagi M, Kawabe S, Chida K, Huh N-H, Kuroki T: Induction of differentiation in normal human keratinocytes by adenovirus-mediated introduction of the eta and delta isoforms of protein kinase C. Mol Cell Biol 18: 5199-5207, 1998
Ishino K, Ohba M, Kawabe M, Chida K, Kuroki T: Phorbol ester-induced G1 arrest in BALB/MK-2 mouse keratinocytes is mediated by delta and eta isoforms of protein kinase C. Japan J Cancer Res (Amsterdam) 89: 1126-1133, 1998
Kashiwagi M, Ohba M, Watanabe H, Ishino K, Kasahara K, Sanai Y, Taya Y, Kuroki T: PKC eta associates with cyclin E/cdk2/p21 complex, phosphorylates p21 and inhibits cdk kinase in keratinocytes. Oncogene 19: 6334-6341, 2000
Osada S, Hashimoto Y, Nomura S, Kohno Y, Chida K, Tajima O, Kubo K, Akimoto K, Koizumi H, Kitamura Y, Suzuki K, Ohno S, Kuroki T: Predominant expression of nPKC eta, a Ca++-independent isoform of protein kinase C in epithelial tissues, in association with epithelial differentiation. Cell Growth Diff 4: 167-175, 1993
Koizumi H, Kohno Y, Osada S, Ohno S, Ohkawara A, Kuroki T: Differentiation-associated localization of nPKC eta, a Ca++-independent protein kinase C, in normal human skin and skin diseases. J Invest Dermatol 101: 858-863, 1993
Doi S, Goldstein D, Hug H, Weinstein IB: Expression of multiple isoforms of protein kinase C in normal human colon mucosa and colon tumors and decreased levels of protein kinase C beta and eta mRNAs in tumors. Mol Carcino 11: 197-203, 1994
Gherzi A, Sparatore B, Patrone M, Sciutto A, Briata P: Protein kinase C mRNA levels and activity in reconstituted normal human epidermis: relationships to cell differentiation. Biochem Biophy Res Commun 184: 283-291, 1992
Beck J, Bohnet B, Brügger D, Bader P, Dietl J, Scheper RJ, Kandolf R, Liu C, Niethammer D, Gekeler V: Multiple gene expression analysis reveals distinct differences between G2 and G3 stage breast cancers, and correlations of PKC eta with MDR1, MRP and LRP gene expression. Br J Cancer 77: 87-91, 1998
Denning MF, Kazanietz MG, Blumberg PM, Yuspa SH: Cholesterol sulfate activates multiple protein kinase C isoenzymes and induces granular cell differentiation in cultured murine keratinocytes. Cell Growth Diff 6: 1619-1626, 1995
Anderson E, Clarke RB, Howell A: Changes in the normal human breast throughout the menstrual cycle: relevance to breast carcinogenesis. Endocrine-Related Cancer 4: 23-33, 1997
Carter D: Overview. In: Interpretation of Breast Biopsies. Lippincott-Raven, Philadelphia, 1996, pp 15-39
Greif H, Ben-Chaim J, Shimon T, Bechor E, Eldar H, Livneh E: The prote in kinase C-related PKC-L(eta) gene product is localized in the cell nucleus. Mol Cell Biol 12: 1304-1311, 1992
Chida K, Sagara H, Suzuki Y, Murakami A, Osada S, Ohno S, Hirosawa K, Kuroki T: The eta isoform of prote in kinase C is localized on rough endoplasmic reticulum. Mol Cell Biol 14: 3782-3790, 1994
Carter D: Anatomy. In: Interpretation of Breast Biopsies. Lippincott-Raven, Philadelphia, 1996, pp 1-14
Asch HL, Winston JS, Edge SB, Stomper PC, Asch BB: Down regulation of gelsolin expression in human breast ductal carcinoma in situ with and without invasion. Breast Cancer Res Treat 55: 179-188, 1999
Asch HL, Head K, Dong Y, Natoli F, Winston JS, Connolly JL, Asch BB: Widespread loss of gelsolin in breast cancers of humans, mice, and rats. Cancer Res 56: 4841-4845, 1996
Livneh E, Shimon T, Bechor E, Doki Y, Schieren I, Weinstein B: Linking protein kinase C to the cell cycle: ectopic expression of PKC eta in NIH3T3 cells alters the expression of cyclins and cdk inhibitors and induces adipogenesis. Oncogene 12: 1545-1555, 1996
Livneh E, Fishman DD: Linking protein kinase C to cell-cycle control. Euro J Biochem 248: 1-9, 1997
Ways DK, Kukoly CA, deVente J, Hooker JL, Bryant WO, Posekany KJ, Fletcher DJ, Cook PP, Parker PJ: MCF-7 breast cancer cells transfected with prote in kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype. J Clin Invest 95: 1906-1915, 1995
Manni A, Buckwalter E, Etindi R, Kunselman S, Rossini A, Mauger D, Dabbs D, Demers L: Induction of a less aggressive breast cancer phenotype by protein kinase C-alpha and-beta overexpression. Cell Growth Diff 7: 1187-1198, 1996
Sun X-G, Rotenberg SA: Overexpression of protein kinase C alpha in MCF-10A human breast cells engenders daramatic alteration in morphology, proliferation, and motility. Cell Growth Diff. 10: 343-352, 1999
Beck J, Regele B, Vrugger D, Dietl J, Kandolf R, Scheper RJ, Niethammer D, Bader P, Hirsch HA, Gekeler V: PKC eta correlates with MDR1, MRP and LRP gene expression in primary breast cancer. Proc Am Assoc Cancer Res 38: 3256-3256, 1997
Vogel PM, Georgiade NG, Fetter BF, Vogel FS, McCarty KS Jr: The correlation of histologic changes in the human breast with the menstrual cycle. Am J Pathol 104: 23-34, 1981
Fanger H, Ree HJ: Cyclic changes in human mammary gland epithelium in relation to the menstrual cycle-an ultrastructural study. Cancer 34: 574-585, 1974
Russo J, Russo IH: Toward a unified concept of mammary carcinogenesis. Prog Clin Biol Res 396: 1-16, 1997
Goodnight JA, Mischak H, Kolch W, Mushinski JF: Immunocytochemical localization of eight prote in kinase C isozymes overexpressed in NIH 3T3 fibroblasts. Isoform-specific association with microfilaments, Golgi, endoplasmic reticulum, and nuclear and cell membranes. J Biol Chem 270: 9991-10001, 1995
Lakhani SR: The transition from hyperplasia to invasive carcinoma of the breast. J Pathol 187: 272-278, 1999
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Masso-Welch, P., Winston, J., Edge, S. et al. Altered expression and localization of PKC eta in human breast tumors. Breast Cancer Res Treat 68, 211–223 (2001). https://doi.org/10.1023/A:1012265703669
Issue Date:
DOI: https://doi.org/10.1023/A:1012265703669